AQR Capital Management
UTMD icon

AQR Capital Management’s Utah Medical Products UTMD Stock Holding History

AQR Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$637K Sell
10,271
-378
-4% -$23.8K ﹤0.01% 3006
2025
Q4 		$596K Sell
10,649
-4,757
-31% -$276K ﹤0.01% 2821
2025
Q3 		$970K Buy
15,406
+6,786
+79% +$401K ﹤0.01% 2451
2025
Q2 		$491K Buy
+8,620
New +$469K ﹤0.01% 2620
2024
Q4 		– Sell
-8,874
Closed -$594K – 2963
2024
Q3 		$594K Buy
8,874
+1,723
+24% +$117K ﹤0.01% 2085
2024
Q2 		$478K Buy
+7,151
New +$487K ﹤0.01% 2072
2022
Q3 		– Sell
-5,346
Closed -$459K – 2326
2022
Q2 		$459K Buy
5,346
+2,218
+71% +$189K ﹤0.01% 1711
2022
Q1 		$281K Buy
+3,128
New +$288K ﹤0.01% 1977
2021
Q1 		– Sell
-4,840
Closed -$408K – 2267
2020
Q4 		$408K Sell
4,840
-9,234
-66% -$787K ﹤0.01% 1859
2020
Q3 		$1.12M Sell
14,074
-58
-0.4% -$4.81K ﹤0.01% 1363
2020
Q2 		$1.25M Sell
14,132
-225
-2% -$20.2K ﹤0.01% 1373
2020
Q1 		$1.35M Buy
14,357
+281
+2% +$26.1K ﹤0.01% 1221
2019
Q4 		$1.52M Sell
14,076
-3,742
-21% -$379K ﹤0.01% 1373
2019
Q3 		$1.71M Sell
17,818
-220
-1% -$20.4K ﹤0.01% 1333
2019
Q2 		$1.73M Sell
18,038
-1,416
-7% -$119K ﹤0.01% 1319
2019
Q1 		$1.72M Sell
19,454
-2,617
-12% -$230K ﹤0.01% 1373
2018
Q4 		$1.83M Sell
22,071
-7,279
-25% -$641K ﹤0.01% 1281
2018
Q3 		$2.77M Buy
29,350
+27,286
+1,322% +$2.61M ﹤0.01% 1249
2018
Q2 		$227K Buy
+2,064
New +$216K ﹤0.01% 2192

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management's UTMD Position: Q1 2026 in Review

AQR Capital Management reduced its Utah Medical Products (UTMD) stake by 3.5% in Q1 2026, selling an estimated $23.8K and leaving 10,271 shares worth $637K. The position accounts for ﹤0.01% of the portfolio, ranked #3006.

AQR Capital Management first reported a position in UTMD in Q2 2018 and has held it in 19 quarters since. The position peaked at $2.77M in Q3 2018. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • AQR Capital Management held 10,271 shares of Utah Medical Products worth $637K as of Q1 2026.
  • AQR Capital Management sold 378 Utah Medical Products shares in Q1 2026, an estimated $23.8K.
  • Utah Medical Products made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3006 holding.
  • AQR Capital Management first reported a position in Utah Medical Products in Q2 2018 and has held it in 19 quarters since.
  • AQR Capital Management's Utah Medical Products position peaked at $2.77M in Q3 2018.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.